Julie Hanson Ostrander
Affiliation: Duke University Medical Center
- Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor statusJulie Hanson Ostrander
Department of Medicine, Division of Medical Oncology, Duke University Medical Center and Department of Biomedical Engineering, Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27710, USA
Cancer Res 70:4759-66. 2010..This source of optical contrast could be a potentially useful tool for drug screening in preclinical models...
- Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapy-induced apoptosisKevin J Chalut
Department of Biomedical Engineering, Fitzpatrick Institute for Photonics, Duke University, Durham, North Carolina 27708, USA
Cancer Res 69:1199-204. 2009..These results suggest that a/LCI may have utility in detecting early apoptotic events for both clinical and basic science applications...
- Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cellsJulie Hanson Ostrander
Department of Medicine, University of Minnesota Cancer Center, Minneapolis, Minnesota 55455, USA
Cancer Res 67:4199-209. 2007..These results place Brk in a novel signaling pathway downstream of ErbB receptors and upstream of Rac, p38 MAPK, and ERK5 and establish the ErbB-Brk-Rac-p38 MAPK pathway as a critical mediator of breast cancer cell migration...